Literature DB >> 18180461

Moving research from bench to bedside to community: there is still more to do.

Katherine L Kahn.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18180461     DOI: 10.1200/JCO.2007.13.1870

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer.

Authors:  Katherine L Kahn; John L Adams; Jane C Weeks; Elizabeth A Chrischilles; Deborah Schrag; John Z Ayanian; Catarina I Kiefe; Patricia A Ganz; Nirmala Bhoopalam; Arnold L Potosky; David P Harrington; Robert H Fletcher
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

2.  A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12).

Authors:  V H C Bramwell; K I Pritchard; D Tu; K Tonkin; H Vachhrajani; T A Vandenberg; J Robert; A Arnold; S E O'Reilly; B Graham; L Shepherd
Journal:  Ann Oncol       Date:  2009-07-23       Impact factor: 32.976

3.  Found in translation: Integrating laboratory and clinical oncology research.

Authors:  H Wagner
Journal:  Biomed Imaging Interv J       Date:  2008-07-01

4.  Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy.

Authors:  Katharina Pachmann; Oumar Camara; Annika Kohlhase; Carola Rabenstein; Torsten Kroll; Ingo B Runnebaum; Klaus Hoeffken
Journal:  J Cancer Res Clin Oncol       Date:  2010-08-08       Impact factor: 4.553

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.